On the contrary, other studies [36] indicated that some of the about 3000 synthetic VDAs produced by different pharmaceutical companies and research groups may interfere with the proliferation of the cancer cells in different cell lines, owing to their binding affinity to VDR. The gene discussed is VDR; the disease is cancer.